Open Menu
HOME
COMPANY
About us
PORIB team
Mission-Values
SERVICES
Health Economic Evaluation
Pricing and Reimbursement
Market Access
Real-World Evidence
Scientific Communication
Healthcare Management
Advisory Boards
Biostatistics
Training
CUSTOMERS
Pharmaceutical Industry
Scientific Societies
Universities and Training Schools
Other Collaborations
PUBLICATIONS
Therapeutic Area
Project Type
Papers
Abstracts
Books
TRAINING
BROCHURES
Corporate Brochure
Health Outcomes Research Brochure
Economic Evaluation Brochure
Statistical Evidence Brochure
en
es
Pharmacoeconomics & Outcomes Research Iberia
CONTACT
|
PORIB FOUNDATION
|
HOME
COMPANY
About us
PORIB team
Mission-Values
SERVICES
Health Economic Evaluation
Pricing and Reimbursement
Market Access
Real-World Evidence
Scientific Communication
Healthcare Management
Advisory Boards
Biostatistics
Training
CUSTOMERS
Pharmaceutical Industry
Scientific Societies
Universities and Training Schools
Other Collaborations
PUBLICATIONS
Therapeutic Area
Project Type
Papers
Abstracts
Books
TRAINING
BROCHURES
Corporate Brochure
Health Outcomes Research Brochure
Economic Evaluation Brochure
Statistical Evidence Brochure
en
es
Home
>
TRAINING
>
Training 2013
>
Nuevas perspectivas en la Evaluación Económica de Fármacos Oncológicos
Nuevas perspectivas en la Evaluación Económica de Fármacos Oncológicos
/
06 Jun 2013
Training 2013
Nuevas perspectivas en la Evaluación Económica de Fármacos Oncológicos
Junio 2013. Granada
Previous Post
V Curso Metodología Gestión Farmacoterapéutica. Impacto Presupuestario
Next Post
Una aproximación práctica al análisis farmacoeconómico en Leucemia Mieloide Crónica
